Zhe Liu
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 detection and testing 3
- Modeling and Simulation top 10%
-
- Cancer Genomics and Diagnostics 6
-
- Pancreatic and Hepatic Oncology Research 16
-
- Epigenetics and DNA Methylation 5
-
- Renal cell carcinoma treatment 3
-
- Remote Sensing in Agriculture 3
- Journals
- Drug Resistance Updates (2 papers)International Journal of Biological Sciences (2 papers)Lubricants (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zhe Liu
89 papers receiving 913 citations
Peers
Comparison fields: 5 of 142
- Infectious Diseases 266
- Neurology 90
- Modeling and Simulation 26
- Cancer Research 75
- Oncology 130
Countries citing papers authored by Zhe Liu
This map shows the geographic impact of Zhe Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Liu more than expected).
Fields of papers citing papers by Zhe Liu
This network shows the impact of papers produced by Zhe Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Liu. The network helps show where Zhe Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhe Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 6 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 8 | |
| 12 | 2024 | 16 | |
| 13 | 2024 | 1 | |
| 14 | 2024 | 10 | |
| 15 | 2024 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 1 | |
| 18 | 2024 | 8 | |
| 19 | 2023 | 5 | |
| 20 | 2021 | 2 |
About Zhe Liu
Zhe Liu is a scholar working on Acoustics and Ultrasonics, Cancer Research and Oncology, having authored 112 papers that have together received 930 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (6 papers), Epigenetics and DNA Methylation (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers), Renal cell carcinoma treatment (3 papers), SARS-CoV-2 detection and testing (3 papers) and Remote Sensing in Agriculture (3 papers). The work is most often cited by research in Infectious Diseases (266 citations), Neurology (90 citations) and Modeling and Simulation (26 citations). Zhe Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jinju Peng, Huifang Lin, Runyu Yuan, Jing Lu, Jiufeng Sun, Changwen Ke, Chumin Liang, Lilian Zeng, Wenjun Ma and Sarah Eskreis‐Winkler. Their work appears in journals such as Drug Resistance Updates, International Journal of Biological Sciences, Lubricants, Biological Psychiatry and Applied Surface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.